Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI.

JAMA. 1994 Apr 6;271(13):985-91.

PMID:
8139083
[PubMed - indexed for MEDLINE]
2.

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J.

JAMA. 1992 Nov 11;268(18):2523-9.

PMID:
1404819
[PubMed - indexed for MEDLINE]
3.
4.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119
[PubMed - indexed for MEDLINE]
5.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2002;(3):CD001747. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001747.

PMID:
12137632
[PubMed - indexed for MEDLINE]
6.

Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease.

Schneider LS, Farlow MR, Henderson VW, Pogoda JM.

Neurology. 1996 Jun;46(6):1580-4.

PMID:
8649552
[PubMed - indexed for MEDLINE]
7.

A double-blind, placebo-controlled study of tacrine in Chinese patients with Alzheimer's disease.

Wong WJ, Liu HC, Fuh JL, Wang SJ, Hsu LC, Wang PN, Sheng WY.

Dement Geriatr Cogn Disord. 1999 Jul-Aug;10(4):289-94.

PMID:
10364647
[PubMed - indexed for MEDLINE]
8.

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

Rogers SL, Doody RS, Mohs RC, Friedhoff LT.

Arch Intern Med. 1998 May 11;158(9):1021-31.

PMID:
9588436
[PubMed - indexed for MEDLINE]
9.

Apolipoprotein E genotype and gender influence response to tacrine therapy.

Farlow MR, Lahiri DK, Poirier J, Davignon J, Hui S.

Ann N Y Acad Sci. 1996 Dec 16;802:101-10.

PMID:
8993489
[PubMed - indexed for MEDLINE]
10.

A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, et al.

N Engl J Med. 1992 Oct 29;327(18):1253-9.

PMID:
1406817
[PubMed - indexed for MEDLINE]
Free Article
12.

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

Morris JC, Cyrus PA, Orazem J, Mas J, Bieber F, Ruzicka BB, Gulanski B.

Neurology. 1998 May;50(5):1222-30.

PMID:
9595967
[PubMed - indexed for MEDLINE]
13.

A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease.

Bae CY, Cho CY, Cho K, Hoon Oh B, Choi KG, Lee HS, Jung SP, Kim DH, Lee S, Choi GD, Cho H, Lee H.

J Am Geriatr Soc. 2000 Dec;48(12):1566-71.

PMID:
11129744
[PubMed - indexed for MEDLINE]
14.

Velnacrine for Alzheimer's disease.

Birks J, Wilcock GG.

Cochrane Database Syst Rev. 2004;(2):CD004748. Review.

PMID:
15106259
[PubMed - indexed for MEDLINE]
15.

Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.

Zemlan FP.

J Neural Transm. 1996;103(8-9):1105-16.

PMID:
9013398
[PubMed - indexed for MEDLINE]
16.

The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

Knopman DS, Knapp MJ, Gracon SI, Davis CS.

Neurology. 1994 Dec;44(12):2315-21.

PMID:
7991118
[PubMed - indexed for MEDLINE]
17.

Safety and efficacy of idebenone versus tacrine in patients with Alzheimer's disease: results of a randomized, double-blind, parallel-group multicenter study.

Gutzmann H, Kühl KP, Hadler D, Rapp MA.

Pharmacopsychiatry. 2002 Jan;35(1):12-8.

PMID:
11819153
[PubMed - indexed for MEDLINE]
18.

A 25-week placebo-controlled study of eptastigmine in patients with Alzheimer disease.

Imbimbo BP, Lucca U, Lucchelli F, Alberoni M, Thal LJ.

Alzheimer Dis Assoc Disord. 1998 Dec;12(4):313-22.

PMID:
9876959
[PubMed - indexed for MEDLINE]
19.

Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.

Rockwood K, Mintzer J, Truyen L, Wessel T, Wilkinson D.

J Neurol Neurosurg Psychiatry. 2001 Nov;71(5):589-95.

PMID:
11606667
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.

Farlow MR, Lahiri DK, Poirier J, Davignon J, Schneider L, Hui SL.

Neurology. 1998 Mar;50(3):669-77.

PMID:
9521254
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk